Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results

Go back to Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results
(NASDAQ: ELDN) Delayed: 3.55 -0.03 (0.84%)
Previous Close $3.58    52 Week High
Open $3.62    52 Week Low
Day High $3.72    P/E N/A 
Day Low $3.43    EPS
Volume 1,215,371